Cyclin-Dependent Kinase 9 (CDK9) Antibody

Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro (By similarity).

Target	Cyclin-Dependent Kinase 9 (CDK9)
Clonality	Polyclonal
Reactivity	Human, Mouse
Tested Applications	ELISA, WB
Host	Rabbit
Recommended dilutions	WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	KLH-conjugated synthetic peptide between 251-278 amino acids from the C-terminal region of mouse Cdk9.
Isotype	IgG
Form	Liquid
Purification	Purified through a protein A column, followed by peptide affinity purification.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	Q99J95 (UniProt, ExPASy)
UniProt Secondary AC	B0R020, Q3U002, Q3UMY2, Q3UPT3, Q3UQI6, Q8BTN0
UniProt Entry Name	CDK9_MOUSE
KEGG	mmu:107951
String	10090.ENSMUSP00000009699
Molecular Weight	Calculated MW: 42.8 kDa
Buffer	PBS containing 0.09% sodium azide.
Specificity	Predicted to react with Rat and Cow Cdk9.
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on Cyclin-Dependent Kinase 9 (CDK9)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue